Results 151 to 160 of about 13,786,890 (306)

2024 Japan Society for Stereotactic and Functional Neurosurgery Guidelines for Stereotactic and Functional Neurosurgery

open access: yesNeurologia Medico-Chirurgica
Clinical Practice Guideline Committee of the Japan Society for Stereotactic and Functional Neurosurgery
doaj   +1 more source

An overview of developing clinical prediction models in family practice

open access: yes
Clinical prediction models are rapidly gaining recognition as valuable tools for enhancing decision-making in family practice. This is driven by the increasing availability of high-quality, routinely collected data.
Manski-Nankervis, Jo Anne Anne E.   +6 more
core   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Real-World Clinical Outcomes and Safety of Montelukast in Pediatric Mild-to-Moderate Asthma: A Retrospective Observational Study

open access: yesJournal of Asthma and Allergy
Amani S Alrossies,1 Khadijah A Al-Mubarak,1 Aymen A Alqurain,2 Eman D El Desouky,3 Ghadah H Alshehri,1 Nawal Alsubaie,1 Ahmed Hattan,4 Ammena Y Binsaleh11Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University ...
Alrossies AS   +7 more
doaj  

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

open access: yesMolecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou   +4 more
wiley   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy